Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Sell
25
KOSS Quote, Financials, Valuation and Earnings
Last price:
$5.13
Seasonality move
:
2.75%
Day range:
$4.99 - $5.18
52-week range:
$2.27 - $18.73
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.95x
P/B ratio:
1.57x
Volume:
17.3K
Avg. volume:
50.7K
1-year change:
106.37%
Market cap:
$48.6M
Revenue:
$12.3M
EPS (TTM):
-$0.08
Earnings Data
Next earnings date for KOSS
May 09
2025
Most recent earnings per share
$0.01
Beat by $0.01
(Jan 31/2025)
Consensus Estimate
--
(Jan 31/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
KOSS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 01/31/2025 | Q4 | -- | $3.6M | $0.01 | -- | -- |
| 11/01/2024 | Q3 | -- | $3.2M | -$0.05 | -- | -- |
| 08/29/2024 | Q2 | -- | $2.9M | -$0.01 | -- | -- |
| 05/09/2024 | Q1 | -- | $2.6M | -$0.03 | -- | -- |
| 02/02/2024 | Q4 | -- | $3.4M | -$0.03 | -- | -- |
| 10/27/2023 | Q3 | -- | -- | -$0.03 | -- | -- |
| 08/24/2023 | Q2 | -- | -- | -$0.03 | -- | -- |
| 05/11/2023 | Q1 | -- | -- | -$0.03 | -- | -- |
| 01/26/2023 | Q4 | -- | -- | -$0.12 | -- | -- |
| 10/28/2022 | Q3 | -- | -- | $1.01 | -- | -- |
| 08/25/2022 | Q2 | -- | -- | $0.04 | -- | -- |
| 05/06/2022 | Q1 | -- | -- | $0.04 | -- | -- |
| 02/03/2022 | Q4 | -- | -- | $0.06 | -- | -- |
| 10/29/2021 | Q3 | -- | -- | -$0.01 | -- | -- |
| 08/19/2021 | Q2 | -- | -- | $0.03 | -- | -- |
| 05/12/2021 | Q1 | -- | -- | -$0.06 | -- | -- |
| 01/28/2021 | Q4 | -- | -- | $0.07 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | $0.02 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | $0.02 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.01 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.03 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.04 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | $0.01 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | $0.02 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | $0.01 | -- | -- |
| 10/25/2018 | Q3 | -- | -- | $0.01 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | $0.05 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$0.10 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$0.40 | -- | -- |
| 10/25/2017 | Q3 | -- | -- | $0.00 | -- | -- |
| 08/24/2017 | Q2 | -- | -- | -$0.01 | -- | -- |
| 05/11/2017 | Q1 | -- | -- | -$0.15 | -- | -- |
| 01/26/2017 | Q4 | -- | -- | $0.02 | -- | -- |
| 10/27/2016 | Q3 | -- | -- | $0.01 | -- | -- |
| 08/18/2016 | Q2 | -- | -- | $0.03 | -- | -- |
| 05/12/2016 | Q1 | -- | -- | $0.12 | -- | -- |
| 01/28/2016 | Q4 | -- | -- | $0.05 | -- | -- |
| 10/29/2015 | Q3 | -- | -- | -$0.01 | -- | -- |
| 08/20/2015 | Q2 | -- | -- | $0.05 | -- | -- |
| 05/07/2015 | Q1 | -- | -- | $0.01 | -- | -- |
Koss Earnings Questions
-
How Much did Koss Generate in Revenue Last Quarter?
Koss reported $3.6M worth of top line sales in its most recent quarter.
-
Did Koss Beat Earnings Last Quarter?
Koss announced earnings per share of $0.01 which represents a beat of analyst forecast a -- per share.
-
Is Koss Profitable?
Koss reported $1.4M that represents $0.15 per share over the last quarter.
-
What is the Analyst Consensus for Koss EPS Next Year?
Koss's earnings are forecast to grow from -$0.10 per share to -- per share next year representing an increase of --.
-
When is Koss's Earnings Date?
Koss's next earnings date is May 9, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
